Post Intubation Laryngeal Hazards in Children in the Pediatric Intensive Care Unit
Launched by ASSIUT UNIVERSITY · Jan 8, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how endotracheal intubation, a procedure where a tube is placed in the throat to help a child breathe, affects the larynx (the voice box) in children. The goal is to find out if this procedure can cause any injury to the larynx, which could help doctors spot problems early on. The study is looking for children between 2 months and 18 years old who have undergone intubation for 24 hours or more, whether it was done in an emergency or planned setting.
Children with certain conditions, such as congenital laryngeal problems or previous surgeries in the head and neck area, won’t be eligible to participate. While the trial is not yet recruiting participants, those who are eligible can expect to be monitored for any potential laryngeal hazards after intubation. This research is important as it aims to improve the safety and care of children who require this procedure in the Pediatric Intensive Care Unit.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age: from 2 month to 18 year
- • 2. Gender: both sexes will be included in the study
- • 3. Endotracheal intubation in emergency or elective sitting for 24hr or more
- Exclusion Criteria:
- • 1-Congenital laryngeal lesions 2-Head and neck surgery 3-CNS infections 4-Craniofacial malformations
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported